| NICE and fair? Health technology assessment policy under the UK’s National Institute for Health and Care Excellence, 1999–2018 V Charlton Health Care Analysis 28 (3), 193-227, 2020 | 80 | 2020 |
| Innovation as a value in healthcare priority-setting: the UK experience V Charlton, A Rid Social justice research 32 (2), 208-238, 2019 | 45 | 2019 |
| National Institute for Health and Care Excellence, social values and healthcare priority setting P Littlejohns, K Chalkidou, AJ Culyer, A Weale, A Rid, K Kieslich, ... Journal of the Royal Society of Medicine 112 (5), 173-179, 2019 | 44 | 2019 |
| Cost effective but unaffordable: an emerging challenge for health systems V Charlton, P Littlejohns, K Kieslich, P Mitchell, B Rumbold, A Weale, ... Bmj 356, 2017 | 44 | 2017 |
| NICE’s new methods: putting innovation first, but at what cost? V Charlton, J Lomas, P Mitchell bmj 379, 2022 | 29 | 2022 |
| Does NICE apply the rule of rescue in its approach to highly specialised technologies? V Charlton Journal of Medical Ethics 48 (2), 118-125, 2022 | 24 | 2022 |
| We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment V Charlton, M DiStefano, P Mitchell, L Morrell, L Rand, G Badano, ... Health Economics, Policy and Law 19 (2), 153-173, 2024 | 19 | 2024 |
| The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies V Charlton Health Economics, Policy and Law 17 (4), 444-470, 2022 | 10 | 2022 |
| Justice, transparency and the guiding principles of the UK’s National Institute for Health and Care Excellence V Charlton Health Care Analysis 30 (2), 115-145, 2022 | 9 | 2022 |
| Exorcising the positivist ghost in the priority-setting machine: NICE and the demise of the ‘social value judgement’ V Charlton, A Weale Health Economics, Policy and Law 16 (4), 505-511, 2021 | 7 | 2021 |
| An empirical ethics study of the coherence of NICE technology appraisal policy and its implications for moral justification V Charlton, M DiStefano BMC Medical Ethics 25 (1), 28, 2024 | 6 | 2024 |
| All health is not equal: the use of modifiers in NICE technology appraisal V Charlton BMJ Evidence-Based Medicine 28 (4), 247-250, 2023 | 6 | 2023 |
| What price is society willing to pay for new drugs? V Charlton The Lancet 405 (10472), 3-5, 2025 | 5 | 2025 |
| Affordability and non-perfectionism in moral action B Rumbold, V Charlton, A Rid, P Mitchell, J Wilson, P Littlejohns, C Max, ... Ethical Theory and Moral Practice 22 (4), 973-991, 2019 | 3 | 2019 |
| The ethical canary: narrow reflective equilibrium as a source of moral justification in healthcare priority-setting V Charlton, MJ DiStefano Journal of medical ethics 50 (12), 835-840, 2024 | 1 | 2024 |
| Innovation, values and NICE's changing societal role V Charlton NICE at 25, 67-89, 2024 | | 2024 |
| We need to talk about values: a proposed framework for the articulation of normative reasoning in V Charlton, M DiStefano, P Mitchell, JF O’Mahony Charlton, Victoria, Michael DiStefano, Polly Mitchell, James F. O’Mahony …, 2024 | | 2024 |
| NICE’s new methods V Charlton, J Lomas, P Mitchell BMJ: British Medical Journal 379, 1-4, 2022 | | 2022 |
| On the ethics of aggregation in cost-effectiveness analysis or,‘Books, bookshelves and the illusion of precision in estimating opportunity cost’ V Charlton Frontiers in Health Services, 2022 | | 2022 |
| The ethics of aggregation in cost-effectiveness analysis or,“on books, bookshelves, and budget impact” V Charlton Frontiers in Health Services 2, 889423, 2022 | | 2022 |
